Series A raise of $11,000,000 for revolutionary forward-looking intravascular ultrasound (IVUS) with radio frequency (RF) ablation catheter to provide interventional cardiologists a safer way to effectively cross CTOs. Experienced management team will oversee the entire project with a focus on design-for-manufacturing and efficient capital use. Patent portfolio currently worth $8,801,966 on median basis and $20,639,747 on mean basis as of 1/1/18.